Cargando…

Triumph of Pneumococcal Conjugate Vaccines: Overcoming a Common Foe

Pneumococcal conjugate vaccine (PCV) has reduced the burden of pneumococcal disease by the near elimination of vaccine serotypes from countries giving a booster dose at >9 months of life. Herd protection, induced by interruption of pneumococcal vaccine type transmission has protected children too...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodgers, Gail L, Whitney, Cynthia G, Klugman, Keith P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482025/ https://www.ncbi.nlm.nih.gov/pubmed/34590137 http://dx.doi.org/10.1093/infdis/jiaa535

Ejemplares similares

Impact of Pneumococcal Conjugate Vaccine on Vaccine Serotype–Specific Pneumonia
por: Klugman, Keith P, et al.
Publicado: (2020)

Surveillance of the impact of pneumococcal conjugate vaccines in developing countries
por: Rodgers, Gail L, et al.
Publicado: (2015)

Population versus individual protection by pneumococcal conjugate vaccination
por: Klugman, Keith P, et al.
Publicado: (2019)

Dosing Schedules for Pneumococcal Conjugate Vaccine: Considerations for Policy Makers
por: Whitney, Cynthia G., et al.
Publicado: (2014)

Systematic Review of the Indirect Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Pneumococcal Disease and Colonization
por: Loo, Jennifer D., et al.
Publicado: (2014)

Why Do We Need a Systematic Review of Pneumococcal Conjugate Vaccine Dosing Schedules?
por: O’Brien, Katherine L., et al.
Publicado: (2014)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children
por: Conklin, Laura, et al.
Publicado: (2014)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Immunogenicity
por: Deloria Knoll, Maria, et al.
Publicado: (2014)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Prevention of Pneumonia
por: Loo, Jennifer D., et al.
Publicado: (2014)

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage
por: Fleming-Dutra, Katherine E., et al.
Publicado: (2014)

The Differential Impact of Coadministered Vaccines, Geographic Region, Vaccine Product and Other Covariates on Pneumococcal Conjugate Vaccine Immunogenicity
por: Park, Daniel E., et al.
Publicado: (2014)

Triumphs of Immunization
por: Modlin, John F, et al.
Publicado: (2021)

PERCH in Perspective: What Can It Teach Us About Pneumonia Etiology in Children?
por: Klugman, Keith P., et al.
Publicado: (2017)

The Real Triumph of Japan or the Conquest of the Silent Foe
por: Seaman, Louis L.
Publicado: (1905)

Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines
por: Sanneh, Bakary, et al.
Publicado: (2019)

Impact of 10-Valent Pneumococcal Conjugate Vaccine on Bacterial Meningitis in Madagascar
por: Andriatahirintsoa, Emilson Jean P R, et al.
Publicado: (2019)

Estimated severe pneumococcal disease cases and deaths before and after pneumococcal conjugate vaccine introduction in children younger than 5 years of age in South Africa
por: von Mollendorf, Claire, et al.
Publicado: (2017)

Changes in the Molecular Epidemiology of Pediatric Bacterial Meningitis in Senegal After Pneumococcal Conjugate Vaccine Introduction
por: Sonko, Mouhamadou A, et al.
Publicado: (2019)

Overcoming the effect of pandemic fatigue on vaccine hesitancy—Will belief in science triumph?
por: Bodas, Moran, et al.
Publicado: (2022)

Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines
por: Alderson, Mark R, et al.
Publicado: (2019)

Hospital-based Surveillance for Pediatric Bacterial Meningitis in the Era of the 13-Valent Pneumococcal Conjugate Vaccine in Ghana
por: Renner, Lorna Awo, et al.
Publicado: (2019)

Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV
por: Nunes, Marta C., et al.
Publicado: (2021)

Direct effects of pneumococcal conjugate vaccines among children in Latin America and the Caribbean
por: Whitney, Cynthia G, et al.
Publicado: (2021)

Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years—Zimbabwe, 2010–2016
por: Dondo, Vongai, et al.
Publicado: (2019)

Declines in Pediatric Bacterial Meningitis in the Republic of Benin Following Introduction of Pneumococcal Conjugate Vaccine: Epidemiological and Etiological Findings, 2011–2016
por: Agossou, Joseph, et al.
Publicado: (2019)

Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine
por: Tagbo, Beckie N, et al.
Publicado: (2019)

Impact of Pneumococcal Conjugate Vaccination of Infants on Pneumonia and Influenza Hospitalization and Mortality in All Age Groups in the United States
por: Simonsen, Lone, et al.
Publicado: (2011)

Progress in Introduction of Pneumococcal Conjugate Vaccine — Worldwide, 2000–2012
por: Wang, Susan A., et al.
Publicado: (2013)

Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010–2016
por: Mpabalwani, Evans M, et al.
Publicado: (2019)

Population Snapshot of Streptococcus pneumoniae Causing Invasive Disease in South Africa Prior to Introduction of Pneumococcal Conjugate Vaccines
por: Ndlangisa, Kedibone M., et al.
Publicado: (2014)

Methods for a Systematic Review of Pneumococcal Conjugate Vaccine Dosing Schedules
por: Loo, Jennifer D., et al.
Publicado: (2014)

HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV)
por: Meiring, Susan, et al.
Publicado: (2016)

Etiology of Bacterial Meningitis Among Children <5 Years Old in Côte d’Ivoire: Findings of Hospital-based Surveillance Before and After Pneumococcal Conjugate Vaccine Introduction
por: Boni-Cisse, Catherine, et al.
Publicado: (2019)

Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction
por: Kourna Hama, Mamadou, et al.
Publicado: (2019)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis—Burkina Faso, 2014–2015
por: Kambiré, Dinanibè, et al.
Publicado: (2018)

Effectiveness of 13-pneumococcal conjugate vaccine (PCV13) against invasive pneumococcal disease in children in the Dominican Republic
por: Tomczyk, Sara, et al.
Publicado: (2018)

Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States
por: McGarry, Lisa J, et al.
Publicado: (2013)

Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies
por: Srikantiah, Padmini, et al.
Publicado: (2021)

Pneumococcal Conjugate Vaccines and Otitis Media
por: Taylor, Sylvia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kd6n1ilu5kiod4tbr9al33u25c